Pretomanid Gets Panel Endorsement As Part Of Regimen, Not Individual Molecule, For Treatment-Resistant Tuberculosis

 
• By Michael Cipriano
  
FDA Advisory Committee Feature image
The Antimicrobial Drugs Advisory Committee voted 14-4 supporting approval of the pretomanid regimen.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers